GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Return-on-Tangible-Asset

Pideka Group (Pideka Group) Return-on-Tangible-Asset : -27.67% (As of Sep. 2021)


View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Pideka Group's annualized Net Income for the quarter that ended in Sep. 2021 was $-6.12 Mil. Pideka Group's average total tangible assets for the quarter that ended in Sep. 2021 was $22.11 Mil. Therefore, Pideka Group's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2021 was -27.67%.

The historical rank and industry rank for Pideka Group's Return-on-Tangible-Asset or its related term are showing as below:

CIMVF's Return-on-Tangible-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.83
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Pideka Group Return-on-Tangible-Asset Historical Data

The historical data trend for Pideka Group's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Return-on-Tangible-Asset Chart

Pideka Group Annual Data
Trend
Return-on-Tangible-Asset

Pideka Group Quarterly Data
Mar20 Jun20 Sep20 Mar21 Jun21 Sep21
Return-on-Tangible-Asset Get a 7-Day Free Trial - - -54.95 -173.37 -27.67

Competitive Comparison of Pideka Group's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pideka Group's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Pideka Group's Return-on-Tangible-Asset falls into.



Pideka Group Return-on-Tangible-Asset Calculation

Pideka Group's annualized Return-on-Tangible-Asset for the fiscal year that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( (+)/ )
=/
= %

Pideka Group's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2021 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Sep. 2021 )  (Q: Jun. 2021 )(Q: Sep. 2021 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Sep. 2021 )  (Q: Jun. 2021 )(Q: Sep. 2021 )
=-6.116/( (22.085+22.129)/ 2 )
=-6.116/22.107
=-27.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2021) net income data.


Pideka Group  (OTCPK:CIMVF) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Pideka Group Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Pideka Group's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Pideka Group (Pideka Group) Business Description

Traded in Other Exchanges
N/A
Address
40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2
Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.